Premia Spine launched the ProMIS™ Fixation System, which features a choice of screw placement techniques in one instrument kit. This launch occurred at the 2016 International Society for Advancement of Spine Surgery (ISASS) meeting.
Surgeons can select a k-wireless technique, direct Skin-to-Screw placement, the Tap-Shidi approach or a traditional reusable Jamshidi technique. Further, the Premia Spine screw features a roughened surface topography intended to support optimal screw/bone response and promote bone growth into the micro-crevices of the screw surface.
Premia Spine was formed in 2011 after acquiring rights to the TOPS™ System from Impliant, which launched in certain ex-U.S. regions during 2013. Premia received FDA 510(k) clearance to market ProMIS in July 2015.
Premia’s TOPS system is designed to stabilize— but not fuse—an affected vertebral level following decompression to alleviate pain from degenerative spondylolisthesis and spinal stenosis. Under Impliant, nearly $70MM was invested to develop and commercialize the TOPS system.
Premia Spine launched the ProMIS™ Fixation System, which features a choice of screw placement techniques in one instrument kit. This launch occurred at the 2016 International Society for Advancement of Spine Surgery (ISASS) meeting.
Surgeons can select a k-wireless technique, direct Skin-to-Screw placement, the Tap-Shidi approach or a...
Premia Spine launched the ProMIS™ Fixation System, which features a choice of screw placement techniques in one instrument kit. This launch occurred at the 2016 International Society for Advancement of Spine Surgery (ISASS) meeting.
Surgeons can select a k-wireless technique, direct Skin-to-Screw placement, the Tap-Shidi approach or a traditional reusable Jamshidi technique. Further, the Premia Spine screw features a roughened surface topography intended to support optimal screw/bone response and promote bone growth into the micro-crevices of the screw surface.
Premia Spine was formed in 2011 after acquiring rights to the TOPS™ System from Impliant, which launched in certain ex-U.S. regions during 2013. Premia received FDA 510(k) clearance to market ProMIS in July 2015.
Premia’s TOPS system is designed to stabilize— but not fuse—an affected vertebral level following decompression to alleviate pain from degenerative spondylolisthesis and spinal stenosis. Under Impliant, nearly $70MM was invested to develop and commercialize the TOPS system.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
